Evolution of Ferment conference to kick off
Summer 2025
BOSTON, Feb. 6, 2025
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building
the leading platform for cell programming and biosecurity, today
announced the 2025 Ferment Series, an evolution of its flagship
annual conference dedicated to advancing Ginkgo's mission of making
biology easier to engineer. Throughout 2025, Ginkgo product teams
will hold a series of focused Ferments at Ginkgo's beautiful event
venue, located at 19 Fid Kennedy Ave in Boston's historic Seaport District, just a
five-minute walk from Ginkgo's headquarters.
Each Ferment in the 2025 series will dive deep into specific
focus areas—spanning Ginkgo's cell engineering and biosecurity
offerings—and highlight how Ginkgo's broad horizontal platform for
engineering biology is enabling transformative solutions across
markets including pharma & biotech, agriculture, industrial
biotech, government, and beyond. Speawkers and panelists will
include Ginkgo experts, partners, and industry leaders who are
applying engineered biology to discover, optimize, and manufacture
cutting-edge products.
Attendees will also get a close look at Ginkgo's technologies
and the innovations they have delivered to partners around the
world. In addition, entirely new products and next-generation
services will be showcased, including Ginkgo Datapoints'
high-throughput AI-driven data generation services; Ginkgo
Automation's Reconfigurable Automation Cart (RAC) systems; and
Ginkgo Biosecurity's product suite anchored by Canopy (persistent,
environmental pathogen monitoring) and Horizon (data-driven global
threat intelligence).
"We made big changes in 2024, and our mission is stronger than
ever," said Jason Kelly, co-founder
and CEO of Ginkgo Bioworks. "Whether you're seeking the perfect
antibody, looking to spin up a data generation engine to train your
biological AI model, outfitting your lab with extensible and
flexible automation, or building a new biosecurity solution to meet
your mission's demands, you can find your needle in our tech stack.
We're excited to show how the platform is evolving, and our new
automation capabilities, expanded AI offerings, and next-gen data
services will all be on full display at our 2025 Ferment event
series. Join us as we celebrate the transformative power of biology
and the foundational advancements being made by pioneers across our
industry."
A larger, platform-wide Ferment will return in 2026, alternating
years with targeted business-specific gatherings.
2025 Ferment Series Calendar
- Summer: Datapoints x AI
Ginkgo Datapoints generates
high-quality data at the scale, price, and speed you need. Learn
more about our new data-generation services (Functional Genomics
& Antibody Developability) and dive into the AI models that
we're deploying and leveraging to accelerate biotech R&D.
- September: Ginkgo Biopharma Solutions
Ginkgo Biopharma Solutions partners to accelerate your preclinical
drug discovery and development research with cutting-edge
automation, AI-driven tools, and world-class scientific expertise.
Our solutions and products streamline research, enhance efficiency,
and empower drug developers to push the boundaries of innovation.
Join us to explore our latest offerings and see how our teams help
bring therapeutics from concept to clinic.
- October: Biosecurity
Exploring the future of biosecurity. Experts from government and
industry will discuss strategies for identifying, monitoring, and
mitigating biological risks.
- November: Automation
Demonstrations of Ginkgo's RAC
Automation systems, plus in-depth tours of the Foundry to
illustrate how large-scale data generation and new automation tech
are fueling breakthroughs in cell programming.
Dates are subject to change.
Ginkgo's Agriculture team is especially excited to meet with
partners, old and new, at World AgriTech in San Francisco (March) and ABIM (October), in
addition to other industry conferences. As a Gold Sponsor of World
AgriTech SF, Ginkgo will be hosting a tour of its R&D facility
in West Sacramento, CA on
March 10, 2025. Find out more about
that pre-summit tour here.
Connect with fellow innovators and leaders, and develop the
relationships and ideas that will shape the future of
biotechnology. For more information about Ginkgo's 2025 Ferment
series and to subscribe to updates, please visit our series home
page,
About Ginkgo Bioworks:
Ginkgo Bioworks is the leading
horizontal platform for cell programming, providing flexible,
end-to-end services that solve challenges for organizations across
diverse markets, from food and agriculture to pharmaceuticals to
industrial and specialty chemicals. Ginkgo Biosecurity is building
and deploying the next-generation infrastructure and technologies
that global leaders need to predict, detect, and respond to a wide
variety of biological threats. For more information, visit
ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or
follow us on social media channels such as X (@Ginkgo and
@Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads
(@GinkgoBioworks), or LinkedIn.
GINKGO BIOWORKS INVESTOR
CONTACT:
investors@ginkgobioworks.com
GINKGO BIOWORKS MEDIA
CONTACT:
press@ginkgobioworks.com
Forward-Looking Statements of Ginkgo Bioworks
This
press release contains certain forward-looking statements within
the meaning of the federal securities laws, including statements
regarding the capabilities and potential success of Ginkgo's cell
engineering and biosecurity offerings. These forward-looking
statements generally are identified by the words "believe," "can,"
"project," "potential," "expect," "anticipate," "estimate,"
"intend," "strategy," "future," "opportunity," "plan," "may,"
"should," "will," "would," "will be," "will continue," "will likely
result," and similar expressions. Forward-looking statements are
predictions, projections and other statements about future events
that are based on current expectations and assumptions and, as a
result, are subject to risks and uncertainties. Many factors could
cause actual future events to differ materially from the
forward-looking statements in this press release, including but not
limited to: (i) volatility in the price of Ginkgo's securities due
to a variety of factors, including changes in the competitive and
highly regulated industries in which Ginkgo operates and plans to
operate, variations in performance across competitors, and changes
in laws and regulations affecting Ginkgo's business, (ii) the
ability to implement business plans, forecasts, and other
expectations, and to identify and realize additional business
opportunities, (iii) the risk of downturns in demand for products
using synthetic biology, (iv) the uncertainty regarding the demand
for passive monitoring programs and biosecurity services, (v)
changes to the biosecurity industry, including due to advancements
in technology, emerging competition and evolution in industry
demands, standards and regulations, (vi) the outcome of any pending
or potential legal proceedings against Ginkgo, (vii) our ability to
realize the expected benefits from and the success of our Foundry
platform programs, (viii) our ability to successfully develop
engineered cells, bioprocesses, data packages or other
deliverables, and (ix) the product development or commercialization
success of our customers. The foregoing list of factors is not
exhaustive. You should carefully consider the foregoing factors and
the other risks and uncertainties described in the "Risk Factors"
section of Ginkgo's annual report on Form 10-K filed with the U.S.
Securities and Exchange Commission (the "SEC") on February 29, 2024, Ginkgo's most recent quarterly
report on Form 10-Q, and other documents filed by Ginkgo from time
to time with the SEC. These filings identify and address other
important risks and uncertainties that could cause actual events
and results to differ materially from those contained in the
forward-looking statements. Forward-looking statements speak only
as of the date they are made. Readers are cautioned not to put
undue reliance on forward-looking statements, and Ginkgo assumes no
obligation and does not intend to update or revise these
forward-looking statements, whether as a result of new information,
future events, or otherwise. Ginkgo does not give any assurance
that it will achieve its expectations.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-host-6th-annual-ferment-as-boston-based-conference-series-302370156.html
SOURCE Ginkgo Bioworks
